All Fresenius Medical Care articles
-
Blog
Fresenius appoints global legal, compliance head
Healthcare company Fresenius Medical Care announced the appointment of Jörg Häring as global head of legal, compliance, and human resources, effective June 1.
-
ArticleQ&A: Compliance Mentor of the Year Mary Shirley
Mary Shirley, head of culture of integrity and compliance education at Fresenius Medical Care, discusses with Compliance Week what mentorship means to her and who has helped her along the way.
-
Article
Fresenius appoints chief legal and compliance officer
Fresenius SE & Co. KGaA, the majority shareholder of Fresenius Medical Care, appointed Dr. Sebastian Biedenkopf to its management board as chief legal and compliance officer and labor relations director.
-
PodcastMary Shirley on traveling in compliance
Mary Shirley, senior director of ethics and compliance at Fresenius Medical Care and a 2019 Top Minds recipient, details to columnist Tom Fox the adjustments she’s made in working in compliance across the globe.
-
ArticleMary Shirley: The great empowerer
Her compliance career has been (literally) all over the map, but Mary Shirley remains fixed on a few key principles: aiming high, helping colleagues advance their careers, and making compliance sexy.
-
ArticleFresenius Medical Care to pay $231M to resolve FCPA case
German healthcare company Fresenius Medical Care reached a $231 million settlement with U.S. authorities for violations of the Foreign Corrupt Practices Act for participating in various corrupt schemes across multiple countries that went undetected for more than a decade.
-
BlogFresenius Medical Care reaches ‘agreement in principle’ in FCPA case
German healthcare company Fresenius Medical Care has reached an “agreement in principle” with U.S. authorities concerning an investigation into possible violations of the Foreign Corrupt Practices Act, booking charges of €224 million (U.S. $255 million) as of Dec. 31, 2018.
-
Blog
Fresenius Medical Care reserves €200 million in FCPA case
Germany-based Fresenius Medical Care, a provider of dialysis products and services, has set aside €200 million concerning its ongoing settlement negotiations with the U.S. government regarding potential violations of the Foreign Corrupt Practices Act.